## Most Common Organism in Lower GI Tract SSI **Key Point:** Bacteroides fragilis is the most common anaerobic organism isolated from surgical site infections of the lower gastrointestinal tract, including appendectomy, colectomy, and rectal surgery. ### Microbiology of Lower GI SSI | Organism | Category | Frequency | Clinical Significance | |----------|----------|-----------|----------------------| | **B. fragilis** | Anaerobic gram-negative rod | 40–60% of anaerobic SSI | Most virulent anaerobe; β-lactamase producer | | C. difficile | Anaerobic gram-positive rod | <5% of SSI | Toxin-mediated; rare in acute SSI | | P. mirabilis | Aerobic gram-negative rod | 5–10% | Urease producer; indole-negative | | K. pneumoniae | Aerobic gram-negative rod | 8–12% | Encapsulated; nosocomial | ### Why B. fragilis Dominates Lower GI SSI 1. **Endogenous source:** Normal colonic flora; concentration ~10^11 CFU/mL in colon 2. **Virulence factors:** - Polysaccharide capsule (antiphagocytic) - β-lactamase production (resistance to penicillins) - Lipopolysaccharide endotoxin 3. **Synergy:** Often isolated with aerobic gram-negatives (E. coli, Klebsiella) in polymicrobial infections 4. **Timing:** Manifests 3–7 days postoperatively (as in this case) **High-Yield:** Lower GI surgery SSI is characteristically **polymicrobial** — anaerobes + aerobes. B. fragilis is the anaerobic component in >50% of cases. This is why prophylaxis for colorectal surgery includes agents covering anaerobes (cefoxitin, cefotetan, ampicillin-sulbactam). ### Clinical Pearl The presence of **multiple organisms (gram-negative rods + anaerobes)** on culture is a red flag for lower GI source. B. fragilis is often isolated alongside E. coli or Klebsiella in a synergistic polymicrobial infection, which is more difficult to treat and has higher morbidity than monomicrobial infection. **Mnemonic: BAGEL** — **B. fragilis = Bacteroides (anaerobic), Abdominal (lower GI), Gram-negative, Endogenous flora, Lower gut** ### Antibiotic Implications - B. fragilis is resistant to clindamycin (~20% resistance) and cephalosporins (intrinsic β-lactamase) - Agents of choice: Carbapenems (meropenem), piperacillin-tazobactam, ampicillin-sulbactam, metronidazole (if combined with aerobic coverage) - Prophylaxis in colorectal surgery: Cefoxitin or cefotetan (covers both aerobes and anaerobes)
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.